APYX (Bovie Medical) רווחיות מכירות לפי רווח גולמי

Apyx Medical relies on its proprietary Renuvion technology for precise tissue correction. The gross margin percentage confirms the efficiency of the model, where the value of 38.40 serves as the current metric. High authority among surgeons facilitates expansion, although demand for aesthetics remains sensitive to economic cycles and disposable income levels.
פילוחי מדדים מקיפים ואנליטיקה עבור Bovie Medical (APYX)

The use of proprietary plasma rejuvenation technology allows Apyx Medical (APYX) to maintain a premium pricing segment, effectively competing with traditional electrosurgery. This metric measures the profit share after deducting direct production costs, determining the business's fundamental margin of safety, which enables the investor to assess real operational efficiency and model sustainability through gross margin volatility.